» Articles » PMID: 34944665

Profiling of Plasma Extracellular Vesicle Transcriptome Reveals That CircRNAs Are Prevalent and Differ Between Multiple Sclerosis Patients and Healthy Controls

Overview
Journal Biomedicines
Date 2021 Dec 24
PMID 34944665
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

(1) Background: Extracellular vesicles (EVs) are released by most cell types and are implicated in several biological and pathological processes, including multiple sclerosis (MS). Differences in the number and cargo of plasma-derived EVs have been described in MS. In this work, we have characterised the EV RNA cargo of MS patients, with particular attention to circular RNAs (circRNAs), which have attracted increasing attention for their roles in physiology and disease and their biomarker potential. (2) Methods: Plasma-derived EVs were isolated by differential centrifugation (20 patients, 8 controls), and RNA-Sequencing was used to identify differentially expressed linear and circRNAs. (3) Results: We found differences in the RNA type distribution, circRNAs being enriched in EVs vs. leucocytes. We found a number of (corrected -value < 0.05) circRNA significantly DE between the groups. Nevertheless, highly structured circRNAs are preferentially retained in leukocytes. Differential expression analysis reports significant differences in circRNA and linear RNA expression between MS patients and controls, as well as between different MS types. (4) Conclusions: Plasma derived EV RNA cargo is not a representation of leukocytes' cytoplasm but a message worth studying. Moreover, our results reveal the interest of circRNAs as part of this message, highlighting the importance of further understanding RNA regulation in MS.

Citing Articles

Circular RNA in Multiple Sclerosis: Pathogenicity and Potential Biomarker Development: A Systematic Review.

Mohammed E Epigenet Insights. 2023; 16:25168657231213195.

PMID: 38033465 PMC: 10687999. DOI: 10.1177/25168657231213195.


Circular RNAs: A New Approach to Multiple Sclerosis.

Sciaccotta R, Murdaca G, Caserta S, Rizzo V, Gangemi S, Allegra A Biomedicines. 2023; 11(11).

PMID: 38001884 PMC: 10669154. DOI: 10.3390/biomedicines11112883.


Systematic Assessment of Small RNA Profiling in Human Extracellular Vesicles.

Wang J, Chen H, Sheng Q, Dawson T, Coffey R, Patton J Cancers (Basel). 2023; 15(13).

PMID: 37444556 PMC: 10340377. DOI: 10.3390/cancers15133446.


Proteomic Research of Extracellular Vesicles in Clinical Biofluid.

Fan S, Poetsch A Proteomes. 2023; 11(2).

PMID: 37218923 PMC: 10204453. DOI: 10.3390/proteomes11020018.


A Comprehensive Exploration of the Transcriptomic Landscape in Multiple Sclerosis: A Systematic Review.

Chiricosta L, Blando S, DAngiolini S, Gugliandolo A, Mazzon E Int J Mol Sci. 2023; 24(2).

PMID: 36674968 PMC: 9862618. DOI: 10.3390/ijms24021448.


References
1.
Li Y, He X, Li Q, Lai H, Zhang H, Hu Z . EV-origin: Enumerating the tissue-cellular origin of circulating extracellular vesicles using exLR profile. Comput Struct Biotechnol J. 2020; 18:2851-2859. PMC: 7588739. DOI: 10.1016/j.csbj.2020.10.002. View

2.
Manna I, Iaccino E, Dattilo V, Barone S, Vecchio E, Mimmi S . Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients. FASEB J. 2018; 32(8):4241-4246. DOI: 10.1096/fj.201701533R. View

3.
Yanez-Mo M, Siljander P, Andreu Z, Bedina Zavec A, Borras F, Buzas E . Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015; 4:27066. PMC: 4433489. DOI: 10.3402/jev.v4.27066. View

4.
Gao Y, Zhang J, Zhao F . Circular RNA identification based on multiple seed matching. Brief Bioinform. 2017; 19(5):803-810. DOI: 10.1093/bib/bbx014. View

5.
Anders S, Pyl P, Huber W . HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics. 2014; 31(2):166-9. PMC: 4287950. DOI: 10.1093/bioinformatics/btu638. View